Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
10.1038/90108
Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001). Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nature Genetics, 28(3), 266–271.

Authors 8
  1. Xiaoling Xu (first)
  2. Wenhui Qiao (additional)
  3. Steven P. Linke (additional)
  4. Liu Cao (additional)
  5. Wen-Mei Li (additional)
  6. Priscilla A. Furth (additional)
  7. Curtis C. Harris (additional)
  8. Chu-Xia Deng (additional)
References 30 Referenced 298
  1. Hill, A.D., Doyle, J.M., McDermott, E.W. & O' Higgins, N.J. Hereditary breast cancer. Br. J. Surg. 84, 1334–1339 (1997). (10.1002/bjs.1800841004) / Br. J. Surg. by AD Hill (1997)
  2. Casey, G. The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9, 88–93 (1997). (10.1097/00001622-199701000-00014) / Curr. Opin. Oncol. by G Casey (1997)
  3. Xu, X. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genet. 22, 37–43 (1999). (10.1038/8743) / Nature Genet. by X Xu (1999)
  4. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860–5865 (1996). (10.1073/pnas.93.12.5860) / Proc. Natl. Acad. Sci. USA by M Lakso (1996)
  5. Vaziri, H. et al. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. Embo. J. 16, 6018–6033. (1997). (10.1093/emboj/16.19.6018) / Embo. J. by H Vaziri (1997)
  6. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552–557 (1995). (10.1038/377552a0) / Nature by J Brugarolas (1995)
  7. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995). (10.1016/0092-8674(95)90039-X) / Cell by C Deng (1995)
  8. Bennett, M. et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282, 290–293. (1998). (10.1126/science.282.5387.290) / Science by M Bennett (1998)
  9. Hakem, R., de la Pompa, J.L., Elia, A., Potter, J. & Mak, T.W. Partial rescue of Brca1 (5–6) early embryonic lethality by p53 or p21 null mutation. Nature Genet. 16, 298–302 (1997). (10.1038/ng0797-298) / Nature Genet. by R Hakem (1997)
  10. Shen, S.X. et al. A targeted disruption of the murine Brca1 gene causes γ-radiation hypersensitivity and genetic instability. Oncogene 17, 3115–3124 (1998). (10.1038/sj.onc.1202243) / Oncogene by SX Shen (1998)
  11. Sah, V.P. et al. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10, 175–180 (1995). (10.1038/ng0695-175) / Nature Genet. by VP Sah (1995)
  12. Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A. & Korsmeyer, S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96–99 (1995). (10.1126/science.270.5233.96) / Science by CM Knudson (1995)
  13. May, P. & May, E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18, 7621–7636 (1999). (10.1038/sj.onc.1203285) / Oncogene by P May (1999)
  14. Andres, J.L. et al. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 16, 2229–2241 (1998). (10.1038/sj.onc.1201752) / Oncogene by JL Andres (1998)
  15. MacLachlan, T.K., Dash, B., Dicker, D.T. & El-Deiry, W. Repression of BRCA1 through a feedback loop involving p53. J. Biol. Chem. 275, 31869–31875 (2000). (10.1074/jbc.M003338200) / J. Biol. Chem. by TK MacLachlan (2000)
  16. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997). (10.1038/387296a0) / Nature by Y Haupt (1997)
  17. Wang, Y. & Eckhart, W. Phosphorylation sites in the amino-terminal region of mouse p53. Proc. Natl. Acad. Sci. USA 89, 4231–4235 (1992). (10.1073/pnas.89.10.4231) / Proc. Natl. Acad. Sci. USA by Y Wang (1992)
  18. Khosravi, R. et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 14973–14977. (1999). (10.1073/pnas.96.26.14973) / Proc. Natl. Acad. Sci. USA by R Khosravi (1999)
  19. Nakagawa, K., Taya, Y., Tamai, K. & Yamaizumi, M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell Biol. 19, 2828–2834 (1999). (10.1128/MCB.19.4.2828) / Mol. Cell Biol. by K Nakagawa (1999)
  20. Cortez, D., Wang, Y., Qin, J. & Elledge, S.J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162–1166 (1999). (10.1126/science.286.5442.1162) / Science by D Cortez (1999)
  21. Shieh, S.Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334 (1997). (10.1016/S0092-8674(00)80416-X) / Cell by SY Shieh (1997)
  22. Shieh, S.Y., Ahn, J., Tamai, K., Taya, Y. & Prives, C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289–300 (2000). (10.1101/gad.14.3.289) / Genes Dev. by SY Shieh (2000)
  23. Tibbetts, R.S. et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152–157 (1999). (10.1101/gad.13.2.152) / Genes Dev. by RS Tibbetts (1999)
  24. Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009–1023 (1996). (10.1016/S0092-8674(00)81302-1) / Cell by R Hakem (1996)
  25. Liu, C.Y., Flesken-Nikitin, A., Li, S., Zeng, Y. & Lee, W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10, 1835–1843 (1996). (10.1101/gad.10.14.1835) / Genes Dev. by CY Liu (1996)
  26. Cressman, V.L. et al. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell Biol. 19, 7061–7075 (1999). (10.1128/MCB.19.10.7061) / Mol. Cell Biol. by VL Cressman (1999)
  27. Deng, C.X. & Brodie, S. Roles of BRCA1 and its interacting proteins. BioEssays 22, 728–737 (2000). (10.1002/1521-1878(200008)22:8<728::AID-BIES6>3.0.CO;2-B) / BioEssays by CX Deng (2000)
  28. Schuyer, M. & Berns, E.M. Is TP53 dysfunction required for BRCA1-associated carcinogenesis? Mol. Cell Endocrinol. 155, 143–152 (1999). (10.1016/S0303-7207(99)00117-3) / Mol. Cell Endocrinol. by M Schuyer (1999)
  29. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992). (10.1038/356215a0) / Nature by LA Donehower (1992)
  30. Linke, S.P., Clarkin, K.C. & Wahl, G.M. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 57, 1171–1179 (1997). / Cancer Res. by SP Linke (1997)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:50 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 4:43 p.m.)
Indexed 3 weeks, 5 days ago (Aug. 7, 2025, 4:35 p.m.)
Issued 24 years, 2 months ago (July 1, 2001)
Published 24 years, 2 months ago (July 1, 2001)
Published Print 24 years, 2 months ago (July 1, 2001)
Funders 0

None

@article{Xu_2001, title={Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis}, volume={28}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/90108}, DOI={10.1038/90108}, number={3}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Xu, Xiaoling and Qiao, Wenhui and Linke, Steven P. and Cao, Liu and Li, Wen-Mei and Furth, Priscilla A. and Harris, Curtis C. and Deng, Chu-Xia}, year={2001}, month=jul, pages={266–271} }